[Guidelines on the management of stable angina pectoris: executive summary].

Authors/Task Force Members, Kim Fox, Chairperson*, Maria Angeles Alonso Garcia, Madrid (Spain), Diego Ardissino, Parma (Italy), Pawel Buszman, Katowice (Poland), Paolo G. Camici, London (UK), Filippo Crea, Roma (Italy), Caroline Daly, London (UK), Guy De Backer, Ghent (Belgium), Paul Hjemdahl, Stockholm (Sweden), José Lopez-Sendon, Madrid (Spain), Jean Marco, Toulouse (France), João Morais, Leiria (Portugal), John Pepper, London (UK), Udo Sechtem, Stuttgart (Germany), Maarten Simoons, Rotterdam (The Netherlands), and Kristian Thygesen, Aarhus (Denmark)

[1]  Jeroen J. Bax,et al.  The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. , 2005, European heart journal.

[2]  W. Frishman,et al.  Noninvasive Coronary Angiography With Multislice Computed Tomography , 2006 .

[3]  Jean-Claude Tardif,et al.  Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. , 2005, European heart journal.

[4]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[5]  Erland Erdmann,et al.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.

[6]  G. Raff,et al.  Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. , 2005, Journal of the American College of Cardiology.

[7]  S. Wildermuth,et al.  Accuracy of MSCT coronary angiography with 64-slice technology: first experience. , 2005, European heart journal.

[8]  J. Sharman,et al.  Determinants of exercise capacity in patients with type 2 diabetes. , 2005, Diabetes care.

[9]  L. Køber,et al.  N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease , 2005 .

[10]  B. Horne,et al.  Which white blood cell subtypes predict increased cardiovascular risk? , 2005, Journal of the American College of Cardiology.

[11]  T. Marwick,et al.  Assessment of diastolic function: what the general cardiologist needs to know , 2005, Heart.

[12]  R. Becker,et al.  Atherothrombotic Disorders: New Insights From Hematology , 2005, Circulation.

[13]  Philip J. Barter,et al.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[14]  Philip Greenland,et al.  The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association. , 2005, Circulation.

[15]  Antonio Colombo,et al.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. , 2005, European heart journal.

[16]  G. Dagenais,et al.  Fluctuating inflammatory markers in patients with stable ischemic heart disease. , 2005, Archives of internal medicine.

[17]  C. Davidson,et al.  Diabetes and coronary revascularization. , 2005, JAMA.

[18]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[19]  R. Phillips,et al.  Hypertensive Heart Disease , 2005, Hypertension Research.

[20]  Seung‐Jung Park,et al.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.

[21]  C Noel Bairey Merz,et al.  Angina with "normal" coronary arteries. , 2005 .

[22]  V. Wong,et al.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. , 2005, The New England journal of medicine.

[23]  G. Opolski,et al.  Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris. , 2005, International journal of cardiology.

[24]  E. Chazov,et al.  Trimetazidine in Angina Combination Therapy-The TACT Study: Trimetazidine versus Conventional Treatment in Patients with Stable Angina Pectoris in a Randomized, Placebo-Controlled, Multicenter Study , 2005, American journal of therapeutics.

[25]  M. Egger,et al.  Risk of cardiovascular events and rofecoxib: cumulative meta-analysis , 2004, The Lancet.

[26]  Feyzullah Güçlü,et al.  Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  H. Katus,et al.  Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. , 2004, The American journal of cardiology.

[28]  M. Pfeffer,et al.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.

[29]  P. Libby,et al.  Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial , 2004 .

[30]  Warren J Manning,et al.  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[31]  G. FitzGerald.  Coxibs and cardiovascular disease. , 2004, The New England journal of medicine.

[32]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[33]  B. Gersh,et al.  Current and future treatment strategies for refractory angina. , 2004, Mayo Clinic proceedings.

[34]  P. D. de Feyter,et al.  Noninvasive multi-slice computed tomography coronary angiography: an emerging clinical modality. , 2004, Journal of the American College of Cardiology.

[35]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[36]  P. Poole‐Wilson,et al.  Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial , 2004, The Lancet.

[37]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[38]  V. Pasceri,et al.  Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study , 2004, Circulation.

[39]  H. Fukuda,et al.  Frequency of Provoked Coronary Spasms in Patients Undergoing Coronary Arteriography Using a Spasm Provocation Test Via Intracoronary Administration of Ergonovine , 2004, Angiology.

[40]  S. Redwood,et al.  Strategies for refractory angina--electric not eclectic? , 2004, International journal of clinical practice.

[41]  E. Antman,et al.  Clopidogrel resistance: a new chapter in a fast-moving story. , 2004, Circulation.

[42]  L. Shaw,et al.  Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[43]  A. Dyer,et al.  Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality: A Meta-Analysis of Cohort Studies , 2004, Circulation.

[44]  C. Pizzi,et al.  Endothelial Function Predicts Future Development of Coronary Artery Disease: A Study of Women With Chest Pain and Normal Coronary Angiograms , 2004, Circulation.

[45]  D. Holmes,et al.  Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. , 2004, American heart journal.

[46]  Jeroen J. Bax,et al.  Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. , 2004, European heart journal.

[47]  S. Underwood.  Imaging techniques in the assessment of myocardial hibernation , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  B. Chaitman,et al.  Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. , 2004, Journal of the American College of Cardiology.

[49]  D. Rader,et al.  Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. , 2004, The New England journal of medicine.

[50]  R. Dowling,et al.  Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. , 2004, The Annals of thoracic surgery.

[51]  P. Höglund,et al.  Early mortality in coronary bypass surgery: the EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. , 2004, The Annals of thoracic surgery.

[52]  J. Pepper,et al.  A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. , 2004, The New England journal of medicine.

[53]  J. Kaski.  Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X) , 2004, Circulation.

[54]  C. Pepine,et al.  A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial , 2004 .

[55]  B. Chaitman,et al.  Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. , 2004, JAMA.

[56]  A. Gotto,et al.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.

[57]  T. Marwick,et al.  Use of tissue Doppler imaging to facilitate the prediction of events in patients with abnormal left ventricular function by dobutamine echocardiography. , 2004, The American journal of cardiology.

[58]  R. Stafford,et al.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence. , 2004, JAMA.

[59]  P. J. Ell,et al.  Myocardial perfusion scintigraphy: the evidence , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[60]  D. Ardissino,et al.  Selection of Drug Therapy in Stable Angina Pectoris , 1998, Cardiovascular Drugs and Therapy.

[61]  G. FitzGerald,et al.  Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[62]  S. Grundy,et al.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[63]  J. Herlitz,et al.  Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics , 2004, European Journal of Clinical Pharmacology.

[64]  Constance K Haan,et al.  Evidence-based guidelines for cardiovascular disease prevention in women. , 2004, Circulation.

[65]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.

[66]  M. Keltai,et al.  Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. , 2003, European heart journal.

[67]  Marek Belohlavek,et al.  Clinical applications of strain rate imaging. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[68]  H. Hense.  Risk factor scoring for coronary heart disease , 2003, BMJ : British Medical Journal.

[69]  M. Yamagishi,et al.  Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[70]  B. Gersh,et al.  Indications for Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in Chronic Stable Angina: Review of the Evidence and Methodological Considerations , 2003, Circulation.

[71]  D. Atar,et al.  Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen , 2003, Heart.

[72]  Nicorandil for angina - an update , 2003, Drug and therapeutics bulletin.

[73]  M. Loebe,et al.  Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial , 2003, Current opinion in cardiology.

[74]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[75]  A. Wierzbicki,et al.  Ezetimibe: a new addition to lipid‐lowering therapy , 2003, International journal of clinical practice.

[76]  S. Pocock,et al.  Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. , 2003, Journal of the American College of Cardiology.

[77]  K. Fox,et al.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[78]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003 .

[79]  Mary Cushman,et al.  Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[80]  C. Patrono.  Aspirin resistance: definition, mechanisms and clinical read‐outs , 2003, Journal of thrombosis and haemostasis : JTH.

[81]  N. Poulter,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial☆ , 2003 .

[82]  Lawrence Joseph,et al.  Evidence for use of coronary stents: a hierarchical bayesian meta-analysis ☆ , 2003 .

[83]  B. Strauer,et al.  Management of the hypertensive patient with coronary insufficiency but without atherosclerosis , 2003, Current opinion in cardiology.

[84]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[85]  Samy I McFarlane,et al.  Heart disease in diabetic patients , 2003, Current diabetes reports.

[86]  N. Freemantle,et al.  The heart failure revascularisation trial (HEART): rationale, design and methodology , 2003, European journal of heart failure.

[87]  J. Kaski,et al.  C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. , 2003, Journal of the American College of Cardiology.

[88]  Jeroen J. Bax,et al.  Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? , 2003, European heart journal.

[89]  S. Pauker,et al.  A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. , 2003, Journal of the American College of Cardiology.

[90]  Jeroen J. Bax,et al.  Impact of percutaneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital. , 2003, The American journal of cardiology.

[91]  W. Klein,et al.  Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials , 2003, Coronary artery disease.

[92]  M. Herregods,et al.  Can regional strain and strain rate measurement be performed during both dobutamine and exercise echocardiography, and do regional deformation responses differ with different forms of stress testing? , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[93]  S. Inzucchi,et al.  Lipid management in patients with diabetes: translating guidelines into action. , 2003, Diabetes care.

[94]  D. Murdoch,et al.  The value of routine non-invasive tests to predict clinical outcome in stable angina. , 2003, European heart journal.

[95]  J. Borer,et al.  Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial , 2003, Circulation.

[96]  P. Jose,et al.  Diagnosis of CAD in patients with diabetes: Who to evaluate , 2003, Current diabetes reports.

[97]  I. Palacios,et al.  Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study , 2003, Heart.

[98]  H. Fukuda,et al.  Limitations of medical therapy in patients with pure coronary spastic angina. , 2003, Chest.

[99]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[100]  C. F. Mädlera,et al.  Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. , 2003, European heart journal.

[101]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Journal of the American College of Cardiology.

[102]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2003, Circulation.

[103]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[104]  D. Sane,et al.  Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical Significance , 2002, Thrombosis and Haemostasis.

[105]  H. Krumholz,et al.  Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. , 2002, JAMA.

[106]  K. Fox,et al.  Is calcium the clue? , 2002, European heart journal.

[107]  E. Antman,et al.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.

[108]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[109]  Joseph S Alpert,et al.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.

[110]  Ameet Bakhai,et al.  Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.

[111]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[112]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[113]  Deborah Grady,et al.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.

[114]  J. Spertus,et al.  Health Status Predicts Long-Term Outcome in Outpatients With Coronary Disease , 2002, Circulation.

[115]  B. Strauer,et al.  Left ventricular remodeling impairs coronary flow reserve in hypertensive patients , 2002, Journal of hypertension.

[116]  G. Mancia,et al.  Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey , 2002, Journal of hypertension.

[117]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[118]  H. Fukuda,et al.  Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine , 2002, Coronary artery disease.

[119]  W. Hillis,et al.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial , 2002, The Lancet.

[120]  Raimondo Ascione,et al.  Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials , 2002, The Lancet.

[121]  Samin K. Sharma,et al.  Refractory angina pectoris: mechanism and therapeutic options. , 2002, Journal of the American College of Cardiology.

[122]  M. Pasic,et al.  The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. , 2002, European heart journal.

[123]  T. Pearson.  New Tools for Coronary Risk Assessment: What Are Their Advantages and Limitations? , 2002, Circulation.

[124]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[125]  N. Freemantle,et al.  What is the place of beta-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (mis)interpretation. , 2002, Progress in cardiovascular diseases.

[126]  Richard Hellman,et al.  The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus : The AACE System of Intensive Diabetes Self-Management — 2002 Update , 2002 .

[127]  G. Sanz,et al.  Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. , 2001, European heart journal.

[128]  D. Grobbee,et al.  Early Outcome After Off-Pump Versus On-Pump Coronary Bypass Surgery: Results From a Randomized Study , 2001, Circulation.

[129]  V. Froelicher,et al.  Clinical and exercise test predictors of all-cause mortality: results from > 6,000 consecutive referred male patients. , 2001, Chest.

[130]  M. Lauer.  Exercise electrocardiogram testing and prognosis. Novel markers and predictive instruments. , 2001, Cardiology clinics.

[131]  M. Quiñones,et al.  Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy , 2001, Circulation.

[132]  K A Eagle,et al.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.

[133]  H. Hemingway,et al.  Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study. , 2001, Social science & medicine.

[134]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[135]  H. Krumholz,et al.  Sex Differences in 2-Year Mortality after Hospital Discharge for Myocardial Infarction , 2001, Annals of Internal Medicine.

[136]  J. Kaski,et al.  Therapeutic options for the management of patients with cardiac syndrome X. , 2001, European heart journal.

[137]  F. Mohr,et al.  Transmyocardial laser revascularization with the holmium:YAG laser: loss of symptomatic improvement after 2 years. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[138]  I. Olivotto,et al.  The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. , 2001, European heart journal.

[139]  F. Chan.  Helicobacter pylori and nonsteroidal anti-inflammatory drugs. , 2001, Gastroenterology clinics of North America.

[140]  I. Shapira,et al.  The value of stress thallium-201 single photon emission CT imaging as a predictor of outcome and long-term prognosis after CABG. , 2001, Journal of medicine.

[141]  Euan A Ashley,et al.  Exercise testing in clinical medicine , 2000, The Lancet.

[142]  B. Burnand,et al.  A Prospective Randomized Trial Comparing Stenting to Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA Trial , 2000 .

[143]  R. Redberg,et al.  Noninvasive diagnostic testing of coronary artery disease in women. , 2000, Cardiology in review.

[144]  A. Keech,et al.  Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project , 2000, Circulation.

[145]  K. Goa,et al.  Nicorandil , 2012, Drugs.

[146]  G. Guyatt,et al.  Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials , 2000, BMJ : British Medical Journal.

[147]  V F Froelicher,et al.  American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. , 2000, Journal of the American College of Cardiology.

[148]  K. Detre,et al.  Clinical trials of revascularization therapy in diabetics. , 2000, Current opinion in cardiology.

[149]  G. Jackson.  Stable angina: maximal medical therapy is not the same as optimal medical therapy. , 2000, International journal of clinical practice.

[150]  E. E. van der Wall,et al.  Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. , 2000, European heart journal.

[151]  C. Held,et al.  Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS). , 2000, European heart journal.

[152]  S. Haffner.  Coronary heart disease in patients with diabetes. , 2000, The New England journal of medicine.

[153]  Bari Investigators.  Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. , 2000, Journal of the American College of Cardiology.

[154]  E. Ford,et al.  Prevalence of nonfatal coronary heart disease among American adults. , 2000, American heart journal.

[155]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[156]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[157]  C. Baigent,et al.  The adverse effects of different doses of aspirin: a systematic overview of randomised trials and observational studies , 2000 .

[158]  L. Shaw,et al.  Current evidence on diagnostic testing in women with suspected coronary artery disease: choosing the appropriate test. , 2000, Cardiology in review.

[159]  K. McDonald,et al.  Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. , 2000, JAMA.

[160]  A. Faggiotto,et al.  State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action. , 1999, Hypertension.

[161]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[162]  D. Waters,et al.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.

[163]  U. Thadani.  Treatment of stable angina. , 1999, Current opinion in cardiology.

[164]  L. V. von Segesser,et al.  Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial. , 1999, Circulation.

[165]  Sankey V. Williams,et al.  ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). , 1999, Journal of the American College of Cardiology.

[166]  F. Atienza,et al.  Assessment of quality of life in patients with chest pain and normal coronary arteriogram (syndrome x) using a specific questionnaire , 1999, Clinical cardiology.

[167]  M. Segal,et al.  Meta-analysis of exercise testing to detect coronary artery disease in women. , 1999, The American journal of cardiology.

[168]  A Hofman,et al.  Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.

[169]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[170]  L. Sharples,et al.  Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial , 1999, The Lancet.

[171]  D. Berman,et al.  The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. , 1999, The American journal of medicine.

[172]  N. Ochi,et al.  Investigation of the most effective provocation test for patients with coronary spastic angina: usefulness of accelerated exercise following hyperventilation. , 1999, Japanese circulation journal.

[173]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[174]  武井泉,et al.  United Kingdom Prospective Diabetes Study (UKPDS) , 1999 .

[175]  C. Schmid,et al.  Safety of nifedipine in angina pectoris: a meta-analysis. , 1999, Hypertension.

[176]  M. Verani,et al.  Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. , 1998, Circulation.

[177]  L. Cortigiani,et al.  Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. , 1998, Journal of the American College of Cardiology.

[178]  T. Wakatsuki,et al.  Left ventricular diastolic properties of hypertensive patients measured by pulsed tissue Doppler imaging. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[179]  H. Bøtker,et al.  Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X. , 1998, The American journal of cardiology.

[180]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[181]  Jeroen J. Bax,et al.  Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[182]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[183]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[184]  S. Haffner,et al.  Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study , 1998, Diabetes Care.

[185]  R. Holman,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[186]  D. Berman,et al.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. , 1998, Circulation.

[187]  T. Marwick.  Current status of stress echocardiography for diagnosis and prognostic assessment of coronary artery disease. , 1998, Coronary artery disease.

[188]  P. Touboul,et al.  Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. , 1998, Journal of the American College of Cardiology.

[189]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[190]  Y. Aizawa,et al.  Correlation between arteriographic and electrocardiographs features during spasm in the left anterior descending coronary artery , 1997, Coronary artery disease.

[191]  A. Salustri,et al.  Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? , 1997, Circulation.

[192]  M. Lauer,et al.  Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. , 1997, Journal of the American College of Cardiology.

[193]  J. Dhainaut,et al.  Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.

[194]  P. Hartigan,et al.  Percutaneous Transluminal Coronary Angioplasty Versus Medical Therapy for Stable Angina Pectoris: Outcomes for Patients With Double-Vessel Versus Single-Vessel Coronary Artery Disease in a Veterans Affairs Cooperative Randomized Trial , 1997 .

[195]  P. Hartigan,et al.  Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS. , 1997, Journal of the American College of Cardiology.

[196]  J. Alpert,et al.  ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American So , 1997, Journal of the American College of Cardiology.

[197]  Randomised-Intervention-Treatment-Angina -Trial-Participants.  Coronary angioplasty versus medical therapy for angina: The second randomised intervention treatment of angina (RITA-2) trial , 1997 .

[198]  V. Froelicher,et al.  Review of studies using multivariable analysis of clinical and exercise test data to predict angiographic coronary artery disease. , 1997, Progress in cardiovascular diseases.

[199]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[200]  P. Hjemdahl,et al.  Calcium antagonist treatment, sympathetic activity and platelet function. , 1997, European heart journal.

[201]  R. Doll,et al.  Alcohol and coronary heart disease reduction among British doctors: confounding or causality? , 1997, European heart journal.

[202]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[203]  P. Poole‐Wilson,et al.  17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. , 1996, Journal of the American College of Cardiology.

[204]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[205]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[206]  F. Pierron,et al.  Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. , 1996, European heart journal.

[207]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[208]  G. Ginsburg,et al.  The evaluation of chest pain in women. , 1996, The New England journal of medicine.

[209]  R. Califf,et al.  Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. , 1996, The Journal of thoracic and cardiovascular surgery.

[210]  R. Califf,et al.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. , 1996, Journal of the American College of Cardiology.

[211]  H. Mickley.  Asymptomatic cardiac ischemia pilot (ACIP) study. , 1996, Journal of the American College of Cardiology.

[212]  K. Koh,et al.  Comparison of clinical and laboratory findings between patients with diffuse three-vessel coronary artery spasm and other types of coronary artery spasm. , 1996, Catheterization and cardiovascular diagnosis.

[213]  G. E. Green,et al.  Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period. , 1996, The New England journal of medicine.

[214]  M Gent,et al.  Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. , 1996, The New England journal of medicine.

[215]  C. Held,et al.  Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) , 1996, European heart journal.

[216]  K. Fox,et al.  Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. , 1996, European heart journal.

[217]  K. Fox,et al.  The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. , 1996, European heart journal.

[218]  Y. Hirota,et al.  Clinical observation of spontaneous anginal attacks and multivessel spasm in variant angina pectoris with normal coronary arteries: evaluation by 24-hour 12-lead electrocardiography with computer analysis. , 1996, Journal of the American College of Cardiology.

[219]  L. Chambless,et al.  Sex differences in mortality after myocardial infarction: is there evidence for an increased risk for women? , 1995, Circulation.

[220]  F. Pileggi,et al.  The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. , 1995, Journal of the American College of Cardiology.

[221]  S. Pocock,et al.  Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.

[222]  B. Psaty,et al.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.

[223]  D. Ardissino,et al.  Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study. , 1995, Journal of the American College of Cardiology.

[224]  Gram Jb,et al.  The Scandinavian Simvastatin Survival Study (4S) , 1995 .

[225]  P A Poole-Wilson,et al.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. , 1995, Journal of the American College of Cardiology.

[226]  H. Krumholz,et al.  Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? , 1995, Circulation.

[227]  N. Curzen,et al.  Detection of ambulatory ischaemia is not of practical clinical value in the routine management of patients with stable angina. A long-term follow-up study. , 1995, European heart journal.

[228]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Soci , 1995, Journal of the American College of Cardiology.

[229]  R A Deyo,et al.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.

[230]  T. Arnim,et al.  Medical treatment to reduce total ischemic burden : total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine , 1995 .

[231]  T. von Arnim.  Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators. , 1995, Journal of the American College of Cardiology.

[232]  M. Emond,et al.  Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.

[233]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[234]  B. Magnani,et al.  Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). , 1994, Journal of the American College of Cardiology.

[235]  C. Hamm,et al.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[236]  S. Yusuf,et al.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. , 1994, Circulation.

[237]  J R Hampton,et al.  Do women with acute myocardial infarction receive the same treatment as men? , 1994, BMJ.

[238]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[239]  P. Deedwania,et al.  Effects of Treatment on Outcome in Mildly Symptomatic Patients With Ischemia During Daily Life: The Atenolol Silent Ischemia Study (ASIST) , 1994, Circulation.

[240]  F. Harrell,et al.  Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. , 1994, Circulation.

[241]  T. Lüscher.  The endothelium and cardiovascular disease--a complex relation. , 1994, The New England journal of medicine.

[242]  J. Georges,et al.  Coronary angioplasty in patients 75 years and older; comparison with coronary bypass surgery. , 1994, European heart journal.

[243]  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. , 1994, BMJ.

[244]  J. Murabito,et al.  Prognosis After the Onset of Coronary Heart Disease An Investigation of Differences in Outcome Between the Sexes According to Initial Coronary Disease Presentation , 1993, Circulation.

[245]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[246]  H. Bonnier,et al.  Initial and long-term results of coronary angioplasty and coronary bypass surgery in patients of 75 or older. , 1993, British heart journal.

[247]  P. Quandalle,et al.  Potassium channel activators in vasospastic angina. , 1993, European heart journal.

[248]  R. Thomas,et al.  Prediction of Cardiovascular Death in Men Undergoing Noninvasive Evaluation for Coronary Artery Disease , 1993, Annals of Internal Medicine.

[249]  R. Macalpin,et al.  Cardiac arrest and sudden unexpected death in variant angina: complications of coronary spasm that can occur in the absence of severe organic coronary stenosis. , 1993, American heart journal.

[250]  D. Mchaffie,et al.  Nonspecific systolic murmurs: an audit of the clinical value of echocardiography. , 1993, The New Zealand medical journal.

[251]  R. Kronmal,et al.  Prevalence of cardiovascular diseases among older adults : the cardiovascular health study , 1993 .

[252]  M. Pfisterer,et al.  Long‐term Benefit of 1‐Year Amiodarone Treatment for Persistent Complex Ventricular Arrhythmias After Myocardial Infarction , 1993, Circulation.

[253]  Robert Califf,et al.  Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease , 1993, Annals of Internal Medicine.

[254]  P Hjemdahl,et al.  Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? , 1992, Journal of hypertension.

[255]  P. Hartigan,et al.  A Comparison of Angioplasty With Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease , 1992 .

[256]  P. Hartigan,et al.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.

[257]  S. Juul-Möller,et al.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. , 1992, Lancet.

[258]  M. Marmot,et al.  Plasma cholesterol concentration and mortality. The Whitehall Study. , 1992, JAMA.

[259]  D. Waters.  Proischemic complications of dihydropyridine calcium channel blockers. , 1991, Circulation.

[260]  K. Mizuno,et al.  Painless myocardial ischemia in elderly patients compared with middle‐aged patients and its relation to treadmill testing and coronary hemodynamics , 1991, Clinical cardiology.

[261]  V. Froelicher,et al.  The prognostic value of exercise capacity: a review of the literature. , 1991, American heart journal.

[262]  D A Clark,et al.  Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). , 1991, Catheterization and cardiovascular diagnosis.

[263]  F. Harrell,et al.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. , 1991, The New England journal of medicine.

[264]  R. Gibson.  The diagnostic and prognostic value of exercise electrocardiography in asymptomatic subjects and stable symptomatic patients , 1991, Current opinion in cardiology.

[265]  Standards of Medical Care for Patients With Diabetes Mellitus , 1991, Diabetes Care.

[266]  K. Brown.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. , 1991, Circulation.

[267]  H. Tunstall-Pedoe,et al.  Prevalence of coronary heart disease in Scotland: Scottish Heart Health Study. , 1990, British heart journal.

[268]  B. Lernfelt,et al.  Coronary heart disease at 70, 75 and 79 years of age: a longitudinal study with special reference to sex differences and mortality. , 1990, Age and ageing.

[269]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[270]  A. LaCroix,et al.  Chest pain and coronary heart disease mortality among older men and women in three communities. , 1990, Circulation.

[271]  M A Hlatky,et al.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). , 1989, The American journal of cardiology.

[272]  R. Vestal,et al.  Management of drug therapy in the elderly. , 1989, The New England journal of medicine.

[273]  F. Crea,et al.  Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X. , 1989, The American journal of cardiology.

[274]  R. Detrano,et al.  Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. , 1989, Circulation.

[275]  A. L'Abbate,et al.  Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1). , 1989, European heart journal.

[276]  Eli Warnock,et al.  The effect of diltiazem on mortality and reinfarction after myocardial infarction. , 1989, The New England journal of medicine.

[277]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. , 1988, JAMA.

[278]  R. Cannon,et al.  "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. , 1988, The American journal of cardiology.

[279]  F. Harrell,et al.  Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. , 1988, Journal of the American College of Cardiology.

[280]  F. Harrell,et al.  Exercise treadmill score for predicting prognosis in coronary artery disease. , 1987, Annals of internal medicine.

[281]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.

[282]  W. Kannel,et al.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.

[283]  A. Reunanen,et al.  Incidence of different manifestations of coronary heart disease in middle-aged Finnish men and women. , 2009, Acta medica Scandinavica.

[284]  W. Wijns,et al.  Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. , 1985, Circulation.

[285]  E. Wallmark,et al.  Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. , 2009, Scandinavian journal of haematology.

[286]  P. Peduzzi,et al.  Relation of severity of symptoms to prognosis in stable angina pectoris. , 1984, The American journal of cardiology.

[287]  B. Chaitman,et al.  Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy. , 1984, Journal of the American College of Cardiology.

[288]  P. Macfarlane,et al.  Prevalence of ischaemic heart disease in middle aged British men. , 1984, British heart journal.

[289]  E. K. Weir,et al.  "Maximal" drug therapy is not necessarily optimal in chronic angina pectoris. , 1984, Journal of the American College of Cardiology.

[290]  Cass Principal Investigators and Their Associates.  Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. , 1984, The New England journal of medicine.

[291]  P. Elwood,et al.  Chest pain in women: a study of prevalence and mortality follow up in south Wales. , 1984, Journal of epidemiology and community health.

[292]  L. T. Sheffield,et al.  Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. , 1984, Journal of the American College of Cardiology.

[293]  R. Okada,et al.  Comparison of exercise perfusion and ventricular function imaging: an analysis of factors affecting the diagnostic accuracy of each technique. , 1984, Journal of the American College of Cardiology.

[294]  H. Roskamm,et al.  Silent Myocardial Ischemia , 1984, Springer Berlin Heidelberg.

[295]  D. Waters,et al.  Spontaneous remission is a frequent outcome of variant angina. , 1983, Journal of the American College of Cardiology.

[296]  G. Diamond.  A clinically relevant classification of chest discomfort. , 1983, Journal of the American College of Cardiology.

[297]  J. Kjekshus,et al.  Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial Infarction , 1982, Circulation.

[298]  J. W. Kennedy,et al.  The Clinical Spectrum of Coronary Artery Disease and Its Surgical and Medical Management, 1974–1979: The Coronary Artery Surgery Study , 1982, Circulation.

[299]  J. Stoker,et al.  Accurate detection of coronary heart disease by new exercise test. , 1982, British heart journal.

[300]  I. Ringqvist,et al.  Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1982, Circulation.

[301]  J. Rouleau,et al.  Survival of Patients with a Strongly Positive Exercise Electrocardiogram , 1982, Circulation.

[302]  G. Borg,et al.  Quantitative evaluation of chest pain. , 2009, Acta medica Scandinavica. Supplementum.

[303]  W. Rogers,et al.  Angiographic Prevalence of High‐risk Coronary Artery Disease in Patient Subsets (CASS) , 1981, Circulation.

[304]  F. Harrell,et al.  Survival in medically treated coronary artery disease. , 1979, Circulation.

[305]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[306]  D. Harrison,et al.  Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram. , 1979, The American journal of cardiology.

[307]  K. Hammermeister,et al.  Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. , 1979, Circulation.

[308]  K. Lee,et al.  The Role of the Exercise Test in the Evaluation of Patients for Ischemic Heart Disease , 1978, Circulation.

[309]  L. Campeau.  Letter: Grading of angina pectoris. , 1976, Circulation.

[310]  H. Kemp.  Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. , 1973, The American journal of cardiology.

[311]  W. Kannel,et al.  Natural history of angina pectoris in the Framingham study. Prognosis and survival. , 1972, The American journal of cardiology.

[312]  R. Bruce,et al.  Comparative Effects of Aging and Coronary Heart Disease on Submaximal and Maximal Exercise , 1969, Circulation.

[313]  M. Prinzmetal,et al.  Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.

[314]  Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .